Emisphere Technologies is a biopharmaceutical company with a focus on the oral delivery of drugs that are typically injected. The company s business strategy is to develop oral forms of drugs that are not currently available or have limited availability in oral form. The company works alone or through licensing agreements with corporate partners. The company s eligen technology has enabled the oral delivery of proteins, peptides, macromolecules and charged organics. The company and its partners have developed oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormones, human growth hormones and cromolyn sodium. Emisphere Technologies is headquartered in Tarrytown, N.Y.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.